title: Glucagon-like peptide-1 (GLP-1) raises blood-brain glucose transfer capacity and hexokinase activity in human brain.
abstract: In hyperglycemia, glucagon-like peptide-1 (GLP-1) lowers brain glucose concentration together with increased net blood-brain clearance and brain metabolism, but it is not known whether this effect depends on the prevailing plasma glucose (PG) concentration. In hypoglycemia, glucose depletion potentially impairs brain function. Here, we test the hypothesis that GLP-1 exacerbates the effect of hypoglycemia. To test the hypothesis, we determined glucose transport and consumption rates in seven healthy men in a randomized, double-blinded placebo-controlled cross-over experimental design. The acute effect of GLP-1 on glucose transfer in the brain was measured by positron emission tomography (PET) during a hypoglycemic clamp (3 mM plasma glucose) with (18)F-fluoro-2-deoxy-glucose (FDG) as tracer of glucose. In addition, we jointly analyzed cerebrometabolic effects of GLP-1 from the present hypoglycemia study and our previous hyperglycemia study to estimate the Michaelis-Menten constants of glucose transport and metabolism. The GLP-1 treatment lowered the vascular volume of brain tissue. Loading data from hypo- to hyperglycemia into the Michaelis-Menten equation, we found increased maximum phosphorylation velocity (V max) in the gray matter regions of cerebral cortex, thalamus, and cerebellum, as well as increased blood-brain glucose transport capacity (T max) in gray matter, white matter, cortex, thalamus, and cerebellum. In hypoglycemia, GLP-1 had no effects on net glucose metabolism, brain glucose concentration, or blood-brain glucose transport. Neither hexokinase nor transporter affinities varied significantly with treatment in any region. We conclude that GLP-1 changes blood-brain glucose transfer and brain glucose metabolic rates in a PG concentration-dependent manner. One consequence is that hypoglycemia eliminates these effects of GLP-1 on brain glucose homeostasis.
authors.affiliation: Department of Biomedicine - Pharmacology, Aarhus University Aarhus, Denmark.
authors.forename: Michael
authors.initials: M
authors.lastname: Gejl
authors.forename: Susanne
authors.initials: S
authors.lastname: Lerche
authors.forename: Lærke
authors.initials: L
authors.lastname: Egefjord
authors.forename: Birgitte
authors.initials: B
authors.lastname: Brock
authors.forename: Niels
authors.initials: N
authors.lastname: Møller
authors.forename: Kim
authors.initials: K
authors.lastname: Vang
authors.forename: Anders B
authors.initials: AB
authors.lastname: Rodell
authors.forename: Bo M
authors.initials: BM
authors.lastname: Bibby
authors.forename: Jens J
authors.initials: JJ
authors.lastname: Holst
authors.forename: Jørgen
authors.initials: J
authors.lastname: Rungby
authors.forename: Albert
authors.initials: A
authors.lastname: Gjedde
keywords: Michaelis-Menten; blood-brain barrier; cerebral glucose transport; cerebral metabolic rate for glucose; glucagon-like peptide -1; hyperglycemia; hypoglycemia
references.citation: Eur J Nucl Med. 1991;18(10):834-7
references.pmid: 1743207
references.citation: J Clin Endocrinol Metab. 2012 Jul;97(7):E1165-9
references.pmid: 22544917
references.citation: Science. 1981 Oct 23;214(4519):456-7
references.pmid: 7027439
references.citation: J Physiol. 1965 Nov;181(1):103-13
references.pmid: 5866278
references.citation: Metabolism. 2000 Dec;49(12):1598-603
references.pmid: 11145123
references.citation: J Clin Endocrinol Metab. 2002 Mar;87(3):1239-46
references.pmid: 11889194
references.citation: Diabetes. 2004 Sep;53(9):2397-403
references.pmid: 15331551
references.citation: Glia. 2010 Jul;58(9):1094-103
references.pmid: 20468051
references.citation: Proc Natl Acad Sci U S A. 1994 Sep 27;91(20):9352-6
references.pmid: 7937768
references.citation: J Cereb Blood Flow Metab. 2005 Jan;25(1):2-16
references.pmid: 15678108
references.citation: Eur J Pharmacol. 2004 Apr 19;490(1-3):147-58
references.pmid: 15094081
references.citation: Am J Physiol Cell Physiol. 2012 Oct 15;303(8):C806-14
references.pmid: 22763120
references.citation: J Cereb Blood Flow Metab. 2007 Nov;27(11):1766-91
references.pmid: 17579656
references.citation: J Neurochem. 2012 May;121(3):407-17
references.pmid: 22353009
references.citation: Expert Opin Ther Targets. 2011 Oct;15(10):1153-62
references.pmid: 21749267
references.citation: Br J Pharmacol. 2009 Aug;157(8):1340-51
references.pmid: 19681866
references.citation: J Clin Invest. 2005 Dec;115(12):3406-8
references.pmid: 16322789
references.citation: Lancet. 1998 Sep 12;352(9131):837-53
references.pmid: 9742976
references.citation: J Cereb Blood Flow Metab. 1990 Mar;10(2):180-9
references.pmid: 2303534
references.citation: Horm Metab Res. 2004 Nov-Dec;36(11-12):830-6
references.pmid: 15655715
references.citation: J Cereb Blood Flow Metab. 1985 Jun;5(2):163-78
references.pmid: 3872872
references.citation: Diabetes. 2001 Aug;50(8):1911-7
references.pmid: 11473055
references.citation: Curr Med Res Opin. 2011 Mar;27(3):547-58
references.pmid: 21222567
references.citation: Diabetes Care. 1999 Jul;22(7):1137-43
references.pmid: 10388979
references.citation: J Neurochem. 1981 Apr;36(4):1463-71
references.pmid: 7264642
references.citation: N Engl J Med. 2004 May 27;350(22):2272-9
references.pmid: 15163777
references.citation: Physiol Rev. 2007 Oct;87(4):1409-39
references.pmid: 17928588
references.citation: J Cereb Blood Flow Metab. 1984 Jun;4(2):241-9
references.pmid: 6725434
references.citation: Diabetes. 2008 Feb;57(2):325-31
references.pmid: 17991759
references.citation: Physiol Rev. 1983 Oct;63(4):1481-535
references.pmid: 6361813
references.citation: J Cereb Blood Flow Metab. 2005 Apr;25(4):527-34
references.pmid: 15703703
references.citation: Expert Opin Pharmacother. 2010 Aug;11(12):2027-35
references.pmid: 20642370
references.citation: J Clin Endocrinol Metab. 2009 Apr;94(4):1236-43
references.pmid: 19174497
references.citation: Diabetologia. 2005 Oct;48(10):2080-9
references.pmid: 16143864
references.citation: Diabetes. 1999 Oct;48(10):1915-21
references.pmid: 10512354
references.citation: Brain Res. 1982 Jun;257(2):237-74
references.pmid: 7104768
references.citation: J Cereb Blood Flow Metab. 2012 Dec;32(12):2201-10
references.pmid: 22968320
references.citation: Acta Neurol Scand. 1983 Jan;67(1):3-25
references.pmid: 6301198
references.citation: J Clin Endocrinol Metab. 2001 May;86(5):1986-90
references.pmid: 11344196
references.citation: J Cereb Blood Flow Metab. 1998 Feb;18(2):154-60
references.pmid: 9469157
references.citation: J Cereb Blood Flow Metab. 2012 Dec;32(12):2146-52
references.pmid: 22929437
references.citation: Diabetologia. 1995 Dec;38(12):1412-8
references.pmid: 8786014
references.citation: J Neurochem. 2009 May;109 Suppl 1:17-23
references.pmid: 19393004